Klein KR, Freeman JLR, Dunn I, Dvergsten C, et al. The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes. Diabetes Care 2021 Feb 23. pii: dc20-2684. doi: 10.2337/dc20-2684.
PMID: 33622669